Children's Oncology Group
childrensoncologygroup.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
443
Active
71
Phase 3
111
Total enrollment
338,504
Pipeline matrix
Showing 40 of 99 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| cyclophosphamide | — | — | 100 | ||||
| etoposide | — | — | 79 | ||||
| cytarabine | — | — | 60 | ||||
| vincristine sulfate | — | — | 93 | ||||
| carboplatin | — | — | 42 | ||||
| Vincristine | — | — | 11 | ||||
| methotrexate | — | — | 57 | ||||
| Calaspargase Pegol | — | — | — | — | 6 | ||
| Dactinomycin | — | — | — | — | 18 | ||
| Irinotecan | — | — | — | 6 | |||
| Doxorubicin | — | — | — | 6 | |||
| doxorubicin hydrochloride | — | — | 62 | ||||
| Cisplatin | — | — | 34 | ||||
| daunorubicin hydrochloride | — | — | 30 | ||||
| ifosfamide | — | — | 27 | ||||
| pegaspargase | — | — | 25 | ||||
| thioguanine | — | — | — | 24 | |||
| dexamethasone | — | — | 29 | ||||
| leucovorin calcium | — | — | 27 | ||||
| Prednisolone | — | — | 8 | ||||
| Thiotepa | — | — | — | 13 | |||
| irinotecan hydrochloride | — | — | — | 13 | |||
| sargramostim | — | — | — | — | 12 | ||
| dexrazoxane hydrochloride | — | — | — | 11 | |||
| mitoxantrone hydrochloride | — | — | — | 8 | |||
| Dinutuximab | — | — | — | — | 3 | ||
| Asparaginase Erwinia chrysanthemi | — | — | — | — | 3 | ||
| prednisone | — | — | 34 | ||||
| therapeutic hydrocortisone | — | — | 15 | ||||
| Melphalan | — | — | — | 13 | |||
| Isotretinoin | — | — | — | 11 | |||
| methylprednisolone | — | — | — | — | 9 | ||
| vinorelbine tartrate | — | — | — | — | 7 | ||
| Busulfan | — | — | — | 7 | |||
| Lomustine | — | — | — | 7 | |||
| Inotuzumab Ozogamicin | — | — | — | — | 2 | ||
| Fludarabine | — | — | — | — | 2 | ||
| Topotecan | — | — | — | — | 2 | ||
| filgrastim | — | — | 70 | ||||
| mercaptopurine | — | — | 29 |
59 more active programs hidden
Next readouts
- 2020-10-31
- 2022-06-30
- 2022-09-30
- 2023-06-30
- 2024-06-30
- 2024-09-30
- 2025-03-31
- 2025-09-30
- 2026-03-31
- 2026-06-30
Top conditions
- Leukemia96
- Sarcoma37
- Neuroblastoma37
- Lymphoma30
- Unspecified Childhood Solid Tumor, Protocol Specific22
- Acute Lymphoblastic Leukemia18
- Recurrent Neuroblastoma15
- Recurrent Childhood Acute Lymphoblastic Leukemia14
Frequently asked questions about Children's Oncology Group
- How many clinical trials does Children's Oncology Group have on ClinicalTrials.gov?
- Children's Oncology Group is listed as the lead sponsor on 443 clinical trials in ClinicalTrials.gov, 71 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Children's Oncology Group's trials are in Phase 3?
- 111 of Children's Oncology Group's trials are in Phase 3, spread across 99 active drug programs.
- What therapeutic areas does Children's Oncology Group focus on?
- Children's Oncology Group's most-studied conditions on ClinicalTrials.gov are Leukemia, Sarcoma, Neuroblastoma, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific.
- When are Children's Oncology Group's next clinical trial readouts?
- Children's Oncology Group has 10 upcoming primary-completion readouts tracked here; the soonest is “Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia”, expected around 2020-10-31.